CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 52 enrolled
Drug / intervention
tacrolimus +1 moredrug
Likely dose
tacrolimus 05mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00982072
NCT00982072Phase 4Completed
CompareCT.gov

Tacrolimus vs Prednisolone for the Treatment Minimal Change Disease

Imperial College Healthcare NHS Trust·interventional·Posted Sep 22, 2009·Updated May 4, 2021

In Brief

A Phase 4 clinical trial evaluating tacrolimus and prednisolone for Minimal Change Disease. Completed, enrolled 52 participants across 1 site.

Detailed Summary

The purpose of this study is to compare the effectiveness of tacrolimus (prograf) versus prednisolone for the treatment of nephrotic syndrome secondary to minimal change disease.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMinimal Change Disease
CountriesUnited Kingdom
Collaborators--

Timeline

Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 22, 2009
Enrollment StartDec 1, 2009
Primary CompletionOct 10, 2019
TodayJul 2, 2026
Enrollment to primary: 9.9 yearsPosted 16.8 years ago

Interventions

tacrolimusdrug

tacrolimus0.05mg/kg bd (levels 6-12ng/ml)

prednisolonedrug

Prednisolone 1mg/kg maximum 60mg od